Designing a novel high-throughput AlphaLISA assay to quantify plasma NHERF1 as a non-small cell lung cancer biomarkerGuifang Du(Chinese PLA General Hospital), Shan Cheng(Capital Medical University)RSC AdvancesJanuary 1, 201510.1039/c5ra16502dCited by 3SaveCiteExport RISWatch citationsRelated PapersCharacterization of Gut Microbiota, Bile Acid Metabolism, and Cytokines in Intrahepatic Cholangiocarcinoma|Hepatology|2019|165Targeting Src family kinase member Fyn by Saracatinib attenuated liver fibrosis in vitro and in vivo|Cell Death and Disease|2020|64The cellular distribution of Na+/H+ exchanger regulatory factor 1 is determined by the PDZ-I domain and regulates the malignant progression of breast cancer|Oncotarget|2016|19